Professor of Medicine Chair of the Digestive Disease & Surgery Institute
Cleveland Clinic, Cleveland
Cleveland Clinic, Cleveland

The concept of “treat-to-target” isn’t new among physicians who treat inflammatory bowel disease, but over time our target has shifted. Previously, we only focused on symptoms: reducing diarrhea and bleeding levels in patients with ulcerative colitis. This symptom-only approach meant that our treatment targets were subjective. For instance, it’s